Company Filing History:
Years Active: 2014-2021
Title: Wei-Chieh Cheng: Innovator in Medical Research
Introduction
Wei-Chieh Cheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of rare diseases. With a total of 3 patents, Cheng's work focuses on innovative solutions that address critical health issues.
Latest Patents
Cheng's latest patents include groundbreaking methods for treating Fabry disease. His research discloses novel uses of a polyhydroxylated pyrrolidine for the manufacture of a medicament aimed at treating this condition. The method involves administering a therapeutically effective amount of a specific compound to alleviate symptoms associated with Fabry disease. Additionally, he has provided insights into the crystal structure of the bacterial bifunctional transglycosylase penicillin-binding protein 1b (PBP1b) and its interactions with inhibitors. This work lays the foundation for rational drug design and the development of new antibiotics.
Career Highlights
Cheng is affiliated with Academia Sinica, a leading research institution in Taiwan. His work has garnered attention for its potential impact on drug development and disease treatment. His innovative approaches have positioned him as a key figure in the medical research community.
Collaborations
Cheng has collaborated with notable researchers, including Chi-Huey Wong and Ting-Jen Rachel Cheng. These partnerships have enhanced the scope and depth of his research, contributing to advancements in the field.
Conclusion
Wei-Chieh Cheng's contributions to medical research and his innovative patents reflect his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of complex diseases.